Trevena
TRVN
#10609
Rank
NZ$0.01 M
Marketcap
NZ$0.02077
Share price
0.00%
Change (1 day)
-99.26%
Change (1 year)

Revenue for Trevena (TRVN)

Revenue in 2024 (TTM): NZ$0.88 Million

According to Trevena's latest financial reports the company's current revenue (TTM ) is NZ$0.94 Million. In 2023 the company made a revenue of NZ$4.94 Million an increase over the revenue in the year 2022 that were of -NZ$0.66 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Trevena from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) NZ$0.88 M-82.14%
2023 NZ$4.94 M-850.56%
2022 -NZ$0.66 Million-179.31%
2021 NZ$0.83 M-80.48%
2020 NZ$4.25 M9140.56%
2019 NZ$0.04 M-99.46%
2018 NZ$8.54 M
2017 N/A-100%
2016 NZ$5.41 M-40.72%
2015 NZ$9.13 M
2014 N/A-100%
2013 NZ$0.16 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
NZ$62.26 B 6,587,995.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
NZ$0.15 B 15,872.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
NZ$12.35 M 1,207.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$111.19 B 11,764,552.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
NZ$0.64 M-31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
NZ$1.12 M 19.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
NZ$0.17 B 18,288.28%๐Ÿ‡บ๐Ÿ‡ธ USA